Tobrex

   
Google
 
Web NewDrugInformation.com

Tobrex


Drug - Tobrex
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Tobramycin
Multiple ingredients are in alphabetical order.

Strength - 0.3%
The potency of the active ingredient(s), Tobramycin. May repeat for multiple part products.

Applicant - ALCON
The firm name holding legal responsibility for Tobrex. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062535
The FDA assigned number to Tobrex. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Tobrex. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 13, 1984
The date Tobrex was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tobrex. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tobrex is in. Format is RX, OTC, DISCN.

Applicant Full Name - Alcon Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Tobrex.

Tobrex